# Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

> **NCT03088280** · PHASE4 · UNKNOWN · sponsor: **Hospital Geral de Fortaleza** · enrollment: 200 (estimated)

## Conditions studied

- Thymoglobulin Dose

## Interventions

- **DRUG:** Thymoglobulin

## Key facts

- **NCT ID:** NCT03088280
- **Lead sponsor:** Hospital Geral de Fortaleza
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06-30
- **Primary completion:** 2018-01-10
- **Final completion:** 2020-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03088280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03088280, "Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03088280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*